6 completed, 4 terminated, 2 unknown. 12 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 6, Terminated 4, Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Abciximab: new trials by email Literature Review of Abciximab trials Research Report on Abciximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intracoronary Abciximab With Clearway Catheter Intracoronary bolus wtih ClearWayâ„¢RX catheter, IV abciximab - Acute Myocardial Infarction | Phase 3 | Terminated | Gennaro Sardella | 150 | 2009-06-01 | 2013-01-04 |
| Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI) Abciximab, Eptifibatide - Infarction, Myocardial | Phase 3 | Completed | GlaxoSmithKline | 429 | 2006-10-01 | 2012-11-27 |
| Abciximab in Wake-up Stroke Abciximab - Stroke | Phase 3 | Terminated | University of Zurich | 50 | 2005-03-01 | 2007-05-03 |
| Myocardial Infarction With ST-Elevation Abciximab, Abciximab placebo - Myocardial Infarction | Phase 3 | Unknown | University Hospital, Strasbourg, France | 292 | 2005-01-01 | 2009-09-17 |
| Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis Abciximab - Stroke, Stenosis | Phase 3 | Terminated | University of Zurich | 100 | 2004-04-01 | 2007-05-03 |
| A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II) Abciximab - Cerebrovascular Accident, Brain Ischemia | Phase 3 | Terminated | Centocor, Inc. | 808 | 2003-10-01 | 2011-05-17 |
| A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse) abciximab placebo; reteplase placebo, abciximab, abciximab, Abciximab; reteplase; abciximab placebo; abciximab, abciximab; reteplase placebo; abciximab placebo; abciximab - Myocardial Infarction | Phase 3 | Completed | Centocor, Inc. | 2461 | 2002-08-01 | 2014-07-31 |
| Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease Balloon Angioplasty, ReoPro - Arterial Occlusive Diseases | Phase 2 / Phase 3 | Unknown | University Hospital Tuebingen | 420 | 2002-01-01 | 2006-09-12 |
| Full Dose Tenecteplase (TNK-tPA) Together With Heparin Sodium, Full Dose Tenecteplase With Enoxaparin, Half Dose Tenecteplase Together With Abciximab and Heparin Sodium in Patients With Acute Myocardial Infarction (AMI) Full dose TNK-tPA, Half dose TNK-tPA, Heparin - Myocardial Infarction | Phase 3 | Completed | Boehringer Ingelheim | 5989 | 2000-05-01 | 2014-07-14 |
| A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention. Placebo, Heparin, Abciximab - Angioplasty, Transluminal, Percutaneous Coronary | Phase 3 | Completed | Centocor, Inc. | 2792 | 1995-02-01 | 2015-05-25 |
| A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty Abciximab, Placebo - Angina, Unstable, Angioplasty, Transluminal, Percutaneous Coronary | Phase 3 | Completed | Centocor, Inc. | 1265 | 1993-05-01 | 2015-05-25 |
| A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty Abciximab, Placebo - Angina, Unstable, Angioplasty, Transluminal, Percutaneous Coronary | Phase 3 | Completed | Centocor, Inc. | 2038 | 1991-11-01 | 2015-06-02 |
Myocardial Infarction (4) · Ischemic Stroke (3) · Stroke (3) · Angina, Unstable (2) · Acute Disease (1) · Arterial Occlusive Diseases (1) · Brain Ischemia (1) · Carotid Stenosis (1) · Constriction, Pathologic (1) · Intracranial Hemorrhages (1) · Peripheral Vascular Diseases (1) · ST Elevation Myocardial Infarction (1)
Centocor, Inc. (5) · University of Zurich (2) · Boehringer Ingelheim (1) · Gennaro Sardella (1) · GlaxoSmithKline (1) · University Hospital Tuebingen (1) · University Hospital, Strasbourg, France (1)
Germany (4) · France (3) · Switzerland (3) · Argentina (1) · Austria (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Denmark (1) · Israel (1) · Italy (1) · Netherlands (1) · Poland (1) · Romania (1)
Ralf W. Baumgartner, MD (2) · Gunnar Tepe, MD (1) · Iris Baumgartner, MD (1) · Mario Siebler, MD (1)
PMID 10208997, PMID 11113041, PMID 15077099, PMID 18032739, PMID 18499565, PMID 19850248, PMID 19850249, PMID 19918189, PMID 20170878, PMID 20670755, PMID 22319064, PMID 8121459, PMID 9164316, PMID 9182212, PMID 9256222